Craig-Hallum initiated coverage of BioHarvest Sciences (BHST) with a Buy rating and $15 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHST:
- BioHarvest Sciences to Announce Q1 2025 Financial Results
- BioHarvest Sciences participates in a conference call with Maxim Group
- BioHarvest Sciences: Strong Financial Performance and Strategic Expansion Drive Buy Rating
- BioHarvest Sciences Reports Strong Revenue Growth and Strategic Expansion
- BioHarvest Sciences Reports Strong Growth Amid Challenges